levothyroxine semaglutide and Thyroid Medication: Safety and Interactions Semaglutide and Levothyroxine: Safe Together?
Description
Funding This study, including the journals Rapid Service Fee, was funded by Novo Nordisk
We reported a case with severe MASH whose condition had ameliorated by switching from conventional GLP-1RAs to tirzepatide
One research paper refers to these drugs as a multifaceted anti-inflammatory agent
For the semaglutide 2.4-mg-containing groups, semaglutide was initiated at 0.25 mg once weekly for the first 4 weeks, with the dose increased to 0.5 mg from weeks 5 to 8, to 1.0 mg from weeks 9 to 12, to 1.7 mg from weeks 13 to 16 and to 2.4 mg from weeks 17 to 71
(2024, May 22)
